semaglutide/tirzepatide injections Maintenance therapy on semaglutide or tirzepatide Semaglutide vs Tirzepatide | Elase
Description
Monitor patients on oral medications dependent on threshold concentrations for efficacy and those with a narrow therapeutic index (e.g., warfarin) when concomitantly administered with ZEPBOUND

Diabetes Obes Metab 24(6):10611071
)
Tirzepatide tends to come up because it has robust data and label based prescribing frameworks

It is a revolutionary GLP-1 receptor agonist that was originally developed for patients with Type 2 diabetes, but when providers and pharmaceutical developers noticed how much weight their patients were losing, they began to study semaglutide exclusively for weight loss

Latest Clinical Research on Retatrutide In a phase 2 clinical trial published in The New England Journal of Medicine (2023), retatrutide demonstrated substantial weight loss over 48 weeks
These check-ups include monitoring vitals, body composition and metabolic indicators
